Principal Financial Group Inc Incyte Corp Transaction History

Principal Financial Group Inc

$172 Billion
Q3 2024

A detailed history of Principal Financial Group Inc transactions in Incyte Corp stock. As of the latest transaction made, Principal Financial Group Inc holds 220,750 shares of INCY stock, worth $15.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

220,750

Previous 247,888 10.95%

Holding current value

$15.8 Million

Previous $15 Million 2.89%

% of portfolio

0.01%

Previous 0.01%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	SELL	$57.33 - $68.61 $1.56 Million - $1.86 Million	-27,138 Reduced 10.95%	220,750 $14.6 Million
Q2 2024 Jul 29, 2024	SELL	$51.18 - $63.75 $279,647 - $348,330	-5,464 Reduced 2.16%	247,888 $15 Million
Q1 2024 Apr 29, 2024	SELL	$56.55 - $66.59 $16,173 - $19,044	-286 Reduced 0.11%	253,352 $14.4 Million
Q4 2023 Feb 07, 2024	SELL	$52.16 - $64.19 $347,124 - $427,184	-6,655 Reduced 2.56%	253,638 $15.9 Million
Q3 2023 Nov 02, 2023	SELL	$57.77 - $65.93 $30,329 - $34,613	-525 Reduced 0.2%	260,293 $15 Million
Q2 2023 Aug 07, 2023	SELL	$60.95 - $75.51 $473,642 - $586,788	-7,771 Reduced 2.89%	260,818 $16.2 Million
Q1 2023 May 09, 2023	BUY	$70.23 - $86.01 $80,975 - $99,169	1,153 Added 0.43%	268,589 $19.4 Million
Q4 2022 Feb 09, 2023	SELL	$67.18 - $84.11 $203,622 - $254,937	-3,031 Reduced 1.12%	267,436 $21.5 Million
Q3 2022 Nov 09, 2022	BUY	$66.18 - $82.86 $1.89 Million - $2.37 Million	28,585 Added 11.82%	270,467 $18 Million
Q2 2022 Aug 10, 2022	BUY	$66.18 - $83.18 $327,855 - $412,073	4,954 Added 2.09%	241,882 $18.4 Million
Q1 2022 May 09, 2022	BUY	$66.02 - $79.71 $185,120 - $223,506	2,804 Added 1.2%	236,928 $18.8 Million
Q4 2021 Feb 09, 2022	SELL	$63.34 - $74.11 $263,367 - $308,149	-4,158 Reduced 1.74%	234,124 $17.2 Million
Q3 2021 Nov 09, 2021	BUY	$68.67 - $84.02 $163,159 - $199,631	2,376 Added 1.01%	238,282 $16.4 Million
Q2 2021 Aug 10, 2021	BUY	$79.87 - $87.53 $118,287 - $129,631	1,481 Added 0.63%	235,906 $0
Q1 2021 May 10, 2021	SELL	$76.02 - $100.5 $1.53 Million - $2.02 Million	-20,094 Reduced 7.89%	234,425 $19.1 Million
Q4 2020 Feb 08, 2021	SELL	$80.74 - $97.7 $1.64 Million - $1.98 Million	-20,265 Reduced 7.37%	254,519 $22.1 Million
Q3 2020 Nov 06, 2020	SELL	$85.07 - $109.69 $846,871 - $1.09 Million	-9,955 Reduced 3.5%	274,784 $0
Q2 2020 Aug 05, 2020	BUY	$74.18 - $108.93 $1.67 Million - $2.45 Million	22,457 Added 8.56%	284,739 $29.6 Million
Q1 2020 May 12, 2020	BUY	$63.18 - $85.97 $22,681 - $30,863	359 Added 0.14%	262,282 $19.2 Million
Q4 2019 Feb 05, 2020	SELL	$73.04 - $95.72 $562,919 - $737,714	-7,707 Reduced 2.86%	261,923 $22.9 Million
Q3 2019 Nov 13, 2019	SELL	$72.82 - $86.52 $255,234 - $303,252	-3,505 Reduced 1.28%	269,630 $20 Million
Q2 2019 Aug 12, 2019	SELL	$73.52 - $88.7 $1.94 Million - $2.34 Million	-26,428 Reduced 8.82%	273,135 $23.2 Million
Q1 2019 May 10, 2019	BUY	$63.56 - $88.17 $318,753 - $442,172	5,015 Added 1.7%	299,563 $25.8 Million
Q4 2018 Feb 14, 2019	BUY	$58.5 - $69.94 $35,217 - $42,103	602 Added 0.2%	294,548 $18.7 Million
Q3 2018 Nov 14, 2018	BUY	$61.75 - $74.23 $411,316 - $494,446	6,661 Added 2.32%	293,946 $20.3 Million
Q2 2018 Aug 13, 2018	BUY	$60.85 - $83.98 $337,534 - $465,837	5,547 Added 1.97%	287,285 $0
Q1 2018 May 14, 2018	BUY	$83.06 - $100.98 $38,789 - $47,157	467 Added 0.17%	281,738 $23.5 Million
Q4 2017 Feb 13, 2018	BUY	$93.56 - $116.6 $1.81 Million - $2.25 Million	19,331 Added 7.38%	281,271 $26.6 Million
Q3 2017 Nov 02, 2017	BUY	$109.15 - $138.27 $28.6 Million - $36.2 Million	261,940	261,940 $30.6 Million

Others Institutions Holding INCY

# of Institutions

643

Shares Held

186M

Call Options Held

714K

Put Options Held

557K

View Full List

About INCYTE CORP

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

More about INCY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.

Account

Principal Financial Group Inc Incyte Corp Transaction History